Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 13/20 | 0.50 |
| ▸ | CSNK1A1 | P48729 | 4/20 | 0.48 |
| ▸ | GSPT1 | P15170 | 2/20 | 0.48 |
| ▸ | SALL4 | Q9UJQ4 | 1/20 | 0.48 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.48 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.46 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.45 |
| ▸ | IKZF2 | Q9UKS7 | 6/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21360441 | 0.91 | CRBN (0.51) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL31091736 | 0.86 | CRBN (0.53) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL21340251 | 0.86 | IKZF1 (0.55) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL20046073 | 0.85 | IKZF1 (0.60) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL29641009 | 0.85 | IKZF1 (0.60) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL20920016 | 0.83 | IKZF1 (0.57) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL21340246 | 0.83 | CRBN (0.51) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL25036239 | 0.79 | DDB1 (0.46) | CRBNDDB1 | |
| SCHEMBL31736599 | 0.79 | CRBN (0.56) | CRBNCSNK1A1GSPT1SALL4IKZF3 | |
| SCHEMBL21340263 | 0.79 | IKZF1 (0.53) | CRBNCSNK1A1GSPT1SALL4IKZF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245178-A1 | PAK4, CSTF2, OR CSTF2T PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | INNOVO THERAPEUTICS, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2024233838-A1 | METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION | RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) | 2024-11-14 | — | — | WO | disclosed |